PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ)

CUSIP: 71426V306

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM NEW
Total 13F shares
2,982,828
Share change
+905,199
Total reported value
$2,872,963
Put/Call ratio
311%
Price per share
$0.96
Number of holders
19
Value change
+$832,609
Number of buys
9
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 71426V306?
CUSIP 71426V306 identifies PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) as of Q3 2018

As of 30 Sep 2018, PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,982,828 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Vanguard Group Inc, BlackRock Inc., Aisling Capital LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, Virtu Financial LLC, BANK OF MONTREAL /CAN/, BRIDGEWAY CAPITAL MANAGEMENT INC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.